JPS5484580A - 11nnaryll1*44dihydro pyridine compound* its manufacture and use - Google Patents

11nnaryll1*44dihydro pyridine compound* its manufacture and use

Info

Publication number
JPS5484580A
JPS5484580A JP14801378A JP14801378A JPS5484580A JP S5484580 A JPS5484580 A JP S5484580A JP 14801378 A JP14801378 A JP 14801378A JP 14801378 A JP14801378 A JP 14801378A JP S5484580 A JPS5484580 A JP S5484580A
Authority
JP
Japan
Prior art keywords
44dihydro
11nnaryll1
manufacture
pyridine compound
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP14801378A
Other languages
English (en)
Inventor
Bozaato Furiidoritsuhi
Haize Arento
Katsuda Sutanisurafu
Kurauke Eeritsuhi
Sutetsuperu Kuruto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS5484580A publication Critical patent/JPS5484580A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
JP14801378A 1977-12-03 1978-12-01 11nnaryll1*44dihydro pyridine compound* its manufacture and use Pending JPS5484580A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772753946 DE2753946A1 (de) 1977-12-03 1977-12-03 1-n-aryl-1,4-dihydropyridine und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
JPS5484580A true JPS5484580A (en) 1979-07-05

Family

ID=6025263

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14801378A Pending JPS5484580A (en) 1977-12-03 1978-12-01 11nnaryll1*44dihydro pyridine compound* its manufacture and use

Country Status (7)

Country Link
EP (1) EP0002231A1 (ja)
JP (1) JPS5484580A (ja)
DE (1) DE2753946A1 (ja)
DK (1) DK546778A (ja)
ES (1) ES475632A1 (ja)
IL (1) IL56105A0 (ja)
IT (1) IT7830474A0 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005517666A (ja) * 2001-12-20 2005-06-16 バイエル・ヘルスケア・アクチェンゲゼルシャフト １，４−ジヒドロ−１，４−ジフェニルピリジン誘導体
US10703601B2 (en) 2011-05-13 2020-07-07 Corning Optical Communications LLC Transformable cable reels and related assemblies and methods

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU42386B (en) * 1981-03-13 1988-08-31 Krka Process for preparing 1,4-dihydro-pyridine derivatives
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
JPS60156671A (ja) * 1984-01-25 1985-08-16 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体およびその製造法
JPS6112662A (ja) * 1984-06-28 1986-01-21 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体及びその製法
NO854021L (no) * 1984-10-26 1986-04-28 Bayer Ag 1,4-dihydropyridin-hydroksyaminer og fremgangsmaate til fremstilling derav.
US4994476A (en) * 1984-10-31 1991-02-19 Bristol-Myers Company Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanolamine moieties
GB8503429D0 (en) * 1985-02-11 1985-03-13 Ici Plc Chemical compounds
GB8503428D0 (en) * 1985-02-11 1985-03-13 Ici Plc Nitrogen-containing compounds
GB2181127B (en) * 1985-08-21 1989-08-02 Glaxo Spa 4-phenyl-dihydropyridine carboxylic acid derivatives
WO2005080372A1 (en) * 2004-02-19 2005-09-01 Bayer Healthcare Ag Dihydropyridinone derivatives
JP3228266U (ja) 2017-06-19 2020-10-22 ジョンルイ フーニン ロボティクス （シェンヤン） カンパニー リミテッド 人との社会的相互作用のための行為を実施するように構成されたロボット

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2616995A1 (de) * 1976-04-17 1977-10-27 Bayer Ag 1.4-dihydropyridine mit schwefelhaltigen substituenten mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2616991A1 (de) * 1976-04-17 1977-10-27 Bayer Ag Heterocyclisch-substituierte schwefelhaltige dihydropyridine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2658804A1 (de) * 1976-12-24 1978-07-06 Bayer Ag Kreislaufbeeinflussende mittel

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005517666A (ja) * 2001-12-20 2005-06-16 バイエル・ヘルスケア・アクチェンゲゼルシャフト １，４−ジヒドロ−１，４−ジフェニルピリジン誘導体
US10703601B2 (en) 2011-05-13 2020-07-07 Corning Optical Communications LLC Transformable cable reels and related assemblies and methods

Also Published As

Publication number Publication date
EP0002231A1 (de) 1979-06-13
DK546778A (da) 1979-06-04
ES475632A1 (es) 1980-01-16
IT7830474A0 (it) 1978-12-01
IL56105A0 (en) 1979-03-12
DE2753946A1 (de) 1979-06-13

Similar Documents

Publication Publication Date Title
JPS5441871A (en) Novel 55hydroxymethyloxazolidinons and its manufacture
JPS53108196A (en) Compound and its application
JPS5481266A (en) 11alkanoyllpyrroline derivatives*manufacture and use
JPS5414378A (en) Complex and its manufacture
JPS53146976A (en) Waterrsoluble ampholite and manufacture thereof
JPS5439090A (en) Betaalactam compound and its preparation
JPS5470284A (en) Novel dihydropyridine compounds*its manufacture and use
JPS5485195A (en) Leaddrich pyrochlor compound and its manufacture
JPS5484580A (en) 11nnaryll1*44dihydro pyridine compound* its manufacture and use
JPS5473784A (en) Substituted quinolylguanidine derivatives and their manufacture and use
JPS5481300A (en) Pyrazinobenzoxy azepins*their manufacture and use
JPS5448786A (en) Betaalactam compound*its manufacture and composition
JPS5498758A (en) Thiazolidinee2*44dione derivative and its manufacture
JPS5473790A (en) Betaalactam compound and manufacture
JPS5452078A (en) 11alkylimidazole and its manufacture
JPS5481237A (en) Alphaaalkyldihydrocinnamaldehydes and manufacture
JPS5490140A (en) Novel compound*its manufacture and use
JPS5395942A (en) New perfumous compound * its preparation and its perfumous compound
JPS545956A (en) Novel compound * production and use thereof
JPS5448796A (en) 22pyridyll1*44dihydropyridine compound*its manufacture and use
JPS5446778A (en) 22guanidinomethyllindoline compound and its manufacture
JPS5448753A (en) Digoxigenine derivatives and manufacture
JPS5476596A (en) Isoquinoline derivative*its manufacture and use
JPS5495583A (en) Aminoalkylthiodibenz oxepins and their precursor
JPS5444686A (en) Sstriazine derivative and its manufacture